[1]
Tabrez, D.S. et al. 2022. Development and validation of GCHSmethod used for trace level determination of carcinogenic Epichlorohydrin impurity in Rivaroxaban. Asian Journal of Pharmaceutical Research and Development. 10, 3 (Jun. 2022), 30–33. DOI:https://doi.org/10.22270/ajprd.v10i3.1123.